Evidence map›Paper›PMID 38547398›Full record

ArticleThe ISME journal2024

Hypervirulent Klebsiella pneumoniae employs genomic island encoded toxins against bacterial competitors in the gut.

Yi Han Tan, Patricio Arros, Camilo Berríos-Pastén, Indrik Wijaya, Wilson H W Chu, Yahua Chen, Guoxiang Cheam, Ahmad Nazri Mohamed Naim, Andrés E Marcoleta, Aarthi Ravikrishnan and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in The ISME journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Frontiers in microbiology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Mobile genetic elements inJournal of bacteriology · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Yi Han TanInfectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, MD4, Level 2, Singapore 117545, Republic of Singapore.
Patricio ArrosGrupo de Microbiología Integrativa, Laboratorio de Biología Estructural y Molecular BEM, Facultad de Ciencias, Departamento de Biología, Universidad de Chile, Las Palmeras 3425 Ñuñoa, Santiago, Chile.
Camilo Berríos-PasténGrupo de Microbiología Integrativa, Laboratorio de Biología Estructural y Molecular BEM, Facultad de Ciencias, Departamento de Biología, Universidad de Chile, Las Palmeras 3425 Ñuñoa, Santiago, Chile.
Indrik WijayaGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore 138672, Republic of Singapore.
Wilson H W ChuNational Public Health Laboratory, National Centre for Infectious Diseases, 16 Jln Tan Tock Seng, Singapore 308442, Republic of Singapore.
Yahua ChenInfectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, MD4, Level 2, Singapore 117545, Republic of Singapore.
Guoxiang CheamInfectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, MD4, Level 2, Singapore 117545, Republic of Singapore.
Ahmad Nazri Mohamed NaimGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore 138672, Republic of Singapore.
Andrés E MarcoletaGrupo de Microbiología Integrativa, Laboratorio de Biología Estructural y Molecular BEM, Facultad de Ciencias, Departamento de Biología, Universidad de Chile, Las Palmeras 3425 Ñuñoa, Santiago, Chile.
Aarthi RavikrishnanGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore 138672, Republic of Singapore.
Niranjan NagarajanInfectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, MD4, Level 2, Singapore 117545, Republic of Singapore.
Rosalba LagosGrupo de Microbiología Integrativa, Laboratorio de Biología Estructural y Molecular BEM, Facultad de Ciencias, Departamento de Biología, Universidad de Chile, Las Palmeras 3425 Ñuñoa, Santiago, Chile.
Yunn-Hwen GanInfectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 5 Science Drive 2, MD4, Level 2, Singapore 117545, Republic of Singapore.
National University of Singapore · SGUniversity of Chile · CLAgency for Science, Technology and Research · SGGenome Institute of Singapore · SGNational Centre for Infectious Diseases · SG

Funding

ANID doctoral scholarshipA*STAR, National Medical Research Council SC18/23-739915-OOEFONDECYT 1221193Maria Ghilardi Venegas FoundationNational Research Foundation NRFMOSTID21-0005National University of SingaporeNUS Research Scholarship
6 · The paper itself

Abstract

The hypervirulent lineages of Klebsiella pneumoniae (HvKp) cause invasive infections such as Klebsiella-liver abscess. Invasive infection often occurs after initial colonization of the host gastrointestinal tract by HvKp. Over 80% of HvKp isolates belong to the clonal group 23 sublineage I that has acquired genomic islands (GIs) GIE492 and ICEKp10. Our analysis of 12 361 K. pneumoniae genomes revealed that GIs GIE492 and ICEKp10 are co-associated with the CG23-I and CG10118 HvKp lineages. GIE492 and ICEKp10 enable HvKp to make a functional bacteriocin microcin E492 (mccE492) and the genotoxin colibactin, respectively. We discovered that GIE492 and ICEKp10 play cooperative roles and enhance gastrointestinal colonization by HvKp. Colibactin is the primary driver of this effect, modifying gut microbiome diversity. Our in vitro assays demonstrate that colibactin and mccE492 kill or inhibit a range of Gram-negative Klebsiella species and Escherichia coli strains, including Gram-positive bacteria, sometimes cooperatively. Moreover, mccE492 and colibactin kill human anaerobic gut commensals that are similar to the taxa found altered by colibactin in the mouse intestines. Our findings suggest that GIs GIE492 and ICEKp10 enable HvKp to kill several commensal bacterial taxa during interspecies interactions in the gut. Thus, acquisition of GIE492 and ICEKp10 could enable better carriage in host populations and explain the dominance of the CG23-I HvKp lineage.

Indexed as

Genomic IslandsKlebsiella pneumoniaePeptidesPolyketidesAnimalsAnti-Bacterial AgentsHumansMiceVirulenceVirulence FactorsAnti-Bacterial AgentscolibactinPeptidesPolyketidesVirulence Factorscolibactincolonizationcommensalgenomic islandguthypervirulentKlebsiella pneumoniaemicrocin

Identifiers

PMID38547398
PMCPMC11020217
OpenAlexW4393280245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.